13F filer · CIK 1562230 ↗
Capital International Investors
You are looking at Q1 2020. See the latest, Q2 2026 →
Reported value
$244.50B
−17% on the quarter before
Positions
400
46 new · 38 sold out
Top 10
30.4%
of the value
Est. gain
−$51.32B
on stocks held all quarter
Est. return
−19.6%
on those stocks since Q4 2019
Positions as of Mar 31, 2020, from Capital International Investors's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
The 24 largest positions, 49% of the reported value, each sized by its share, colored by what the fund did with it since Q4 2019. Striped tiles are options.
Largest buys
Since Q4 2019, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Gilead Sciences Inc~$3.25BAdded · 0.3% → 1.7%+43,464,551 shares
- Aon Plc Cl A~$1.53BNew · 0.0% → 0.6%+9,278,248 shares
- Broadcom~$1.15BAdded · 3.2% → 3.3%+4,864,220 shares
- Netflix~$1.10BAdded · 1.2% → 2.1%+2,936,451 shares
- Raytheon Technologies Corp~$1.09BNew · 0.0% → 0.4%+11,572,865 shares
- Truist Financial Corp~$1.07BAdded · 0.5% → 0.8%+34,627,221 shares
- Meta~$1.07BAdded · 3.2% → 3.5%+6,394,036 shares
- KLA~$942.6MAdded · 0.1% → 0.5%+6,557,634 shares
- Comcast Corp Cl A~$886.1MAdded · 2.0% → 2.2%+25,775,072 shares
- Enbridge Inc~$816.6MAdded · 1.7% → 1.9%+28,059,331 shares
Largest sells
Since Q4 2019, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Aon Plc Cl A~$1.48BSold out · 0.5% → 0.0%−7,127,161 shares
- Intel~$1.46BCut · 2.9% → 2.6%−26,935,505 shares
- Unitedhealth Group Inc~$1.38BCut · 2.6% → 2.1%−5,514,864 shares
- United Technologies Corp~$1.32BSold out · 0.4% → 0.0%−8,820,088 shares
- Coca-Cola Co~$1.24BCut · 1.1% → 0.5%−28,026,702 shares
- Merck And Co Inc~$904.7MCut · 1.2% → 0.9%−11,758,484 shares
- Fiserv Inc~$904.5MCut · 0.5% → 0.1%−9,521,764 shares
- Texas Instruments~$903.7MCut · 0.5% → 0.1%−9,043,375 shares
- Ross Stores Inc~$877.9MCut · 0.4% → 0.0%−10,095,060 shares
- United Parcel Service Inc Cl B~$586.1MSold out · 0.2% → 0.0%−5,006,661 shares
Holdings
As of Mar 31, 2020. Changes are in shares against Dec 31, 2019, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| MicrosoftCOMMON STOCK · shares +3.5% · price +0.0% | 6.7% | $16.33B | +$1.0M | ||||||||
| AmazonCOMMON STOCK · shares +7.3% · price +5.5% | 3.7% | $8.97B | +$436.8M | ||||||||
| MetaCOMMON STOCK · shares +14% · price −18.7% | 3.5% | $8.60B | −$1.74B | ||||||||
| BroadcomCOMMON STOCK · shares +16% · price −25.0% | 3.3% | $8.16B | −$2.33B | ||||||||
| IntelCOMMON STOCK · shares −19% · price −9.6% | 2.6% | $6.26B | −$662.3M | ||||||||
| Comcast Corp Cl ACOMMON STOCK · shares +19% · price −23.5% | 2.2% | $5.49B | −$1.42B | ||||||||
| AlphabetCOMMON STOCK · shares +5.0% · price −13.0% | 2.2% | $5.30B | −$755.6M | ||||||||
| NetflixCOMMON STOCK · shares +27% · price +16.0% | 2.1% | $5.14B | +$558.7M | ||||||||
| Unitedhealth Group IncCOMMON STOCK · shares −21% · price −15.2% | 2.1% | $5.07B | −$906.7M | ||||||||
| Northrop Grumman CorpCOMMON STOCK · shares +1.3% · price −12.0% | 2.0% | $4.96B | −$671.1M | ||||||||
| Charter Communications Inc Cl ACOMMON STOCK · shares −5.1% · price −10.1% | 1.9% | $4.66B | −$520.9M | ||||||||
| Enbridge IncCOMMON STOCK · shares +22% · price −26.8% | 1.9% | $4.53B | −$1.36B | ||||||||
| Abbott LaboratoriesCOMMON STOCK · shares +18% · price −9.2% | 1.8% | $4.40B | −$376.3M | ||||||||
| Gilead Sciences IncCOMMON STOCK · shares +337% · price +15.1% | 1.7% | $4.21B | +$126.2M | ||||||||
| Activision Blizzard IncCOMMON STOCK · shares +4.0% · price +0.1% | 1.4% | $3.53B | +$3.4M | ||||||||
| Visa Inc.COMMON STOCK · shares +6.1% · price −14.3% | 1.4% | $3.53B | −$552.5M | ||||||||
| Philip Morris InternationalCOMMON STOCK · shares +20% · price −14.3% | 1.3% | $3.21B | −$444.9M | ||||||||
| Eli LillyCOMMON STOCK · shares −13% · price +5.5% | 1.3% | $3.16B | +$166.0M | ||||||||
| Chevron CorpCOMMON STOCK · shares +13% · price −39.9% | 1.1% | $2.67B | −$1.57B | ||||||||
| Humana IncCOMMON STOCK · shares −17% · price −14.3% | 1.1% | $2.62B | −$438.4M | ||||||||
| Crown Castle Intl Corp (Reit)COMMON STOCK · shares +50% · price +1.6% | 0.97% | $2.36B | +$24.6M | ||||||||
| Chubb LtdCOMMON STOCK · shares −0.2% · price −28.2% | 0.95% | $2.33B | −$915.6M | ||||||||
| Jpmorgan Chase And CoCOMMON STOCK · shares −8.7% · price −35.4% | 0.92% | $2.25B | −$1.23B | ||||||||
| Johnson And JohnsonCOMMON STOCK · shares +14% · price −10.1% | 0.90% | $2.19B | −$217.0M | ||||||||
| Merck And Co IncCOMMON STOCK · shares −30% · price −15.4% | 0.88% | $2.14B | −$390.5M | ||||||||
| Total · 400 positions | 100% | $244.50B | −$51.32B |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q4 2019 to Q1 2020: 354 stocks held throughout, down $51.32B (−19.6%).
- Netflix+$558.7M+16%
- Amazon+$436.8M+6%
- Regeneron Pharmaceuticals+$171.2M+30%
- Eli Lilly+$166.0M+6%
- Gilead Sciences Inc+$126.2M+15%
- Chevron Corp−$1.57B−40%
- Meta−$1.74B−19%
- Boeing Co−$1.76B−54%
- Eog Resources Inc−$2.06B−57%
- Broadcom−$2.33B−25%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out, 2 splits read into the share counts.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 12, 2026 | $483.61B+13% | SEC ↗ |
| Q1 2026 | May 13, 2026 | $426.52B−33% | SEC ↗ |
| Q4 2025 | Feb 11, 2026 | $637.97B+3% | SEC ↗ |
| Q3 2025 | Nov 13, 2025 | $619.40B+7% | SEC ↗ |
| Q2 2025 | Aug 13, 2025 | $580.56B+14% | SEC ↗ |
| Q1 2025 | May 12, 2025 | $508.52B−4% | SEC ↗ |
| Q4 2024 | Feb 13, 2025 | $532.30B+2% | SEC ↗ |
| Q3 2024 | Nov 13, 2024 | $520.97B+7% | SEC ↗ |
| Q2 2024 | Aug 13, 2024 | $485.73B−2% | SEC ↗ |
| Q1 2024 | May 14, 2024 | $493.90B+11% | SEC ↗ |
| Q4 2023 | Feb 13, 2024 | $446.09B+13% | SEC ↗ |
| Q3 2023 | Nov 13, 2023 | $394.11B−5% | SEC ↗ |
| Q2 2023 | Aug 11, 2023 | $414.45B+7% | SEC ↗ |
| Q1 2023 | May 15, 2023 | $388.71B+4% | SEC ↗ |
| Q4 2022 | Feb 14, 2023 | $372.54B+9% | SEC ↗ |
| Q3 2022 | Nov 14, 2022 | $342.83B−7% | SEC ↗ |
| Q2 2022 | Aug 15, 2022 | $367.64B−16% | SEC ↗ |
| Q1 2022 | May 19, 2022 (amended) | $438.61B−7% | SEC ↗ |
| Q4 2021 | Feb 14, 2022 | $473.03B+8% | SEC ↗ |
| Q3 2021 | Nov 15, 2021 | $437.44B−0% | SEC ↗ |
| Q2 2021 | Aug 16, 2021 | $437.89B+11% | SEC ↗ |
| Q1 2021 | May 14, 2021 | $395.24B+8% | SEC ↗ |
| Q4 2020 | Feb 12, 2021 | $366.38B+13% | SEC ↗ |
| Q3 2020 | Nov 13, 2020 | $323.46B+6% | SEC ↗ |
| Q2 2020 | Aug 14, 2020 | $305.21B+25% | SEC ↗ |
| Q1 2020 | May 15, 2020 | $244.50B−17% | SEC ↗ |
| Q4 2019 | Feb 18, 2020 | $294.42B+12% | SEC ↗ |
| Q3 2019 | Nov 14, 2019 | $261.94B+5% | SEC ↗ |
| Q2 2019 | Aug 14, 2019 | $250.64B+8% | SEC ↗ |
| Q1 2019 | May 15, 2019 | $232.80B+16% | SEC ↗ |
| Q4 2018 | Feb 14, 2019 | $200.60B−8% | SEC ↗ |
| Q3 2018 | Nov 14, 2018 | $218.36B+147% | SEC ↗ |
| Q2 2018 | Aug 14, 2018 | $88.55B+2% | SEC ↗ |
| Q1 2018 | May 15, 2018 | $86.51B−2% | SEC ↗ |
| Q4 2017 | Feb 14, 2018 | $88.52B+6% | SEC ↗ |
| Q3 2017 | Nov 14, 2017 | $83.48B+11% | SEC ↗ |
| Q2 2017 | Aug 14, 2017 | $74.88B+2% | SEC ↗ |
| Q1 2017 | May 15, 2017 | $73.61B+6% | SEC ↗ |
| Q4 2016 | Feb 15, 2017 | $69.28B+0% | SEC ↗ |
| Q3 2016 | Nov 14, 2016 | $68.95B+1% | SEC ↗ |
| Q2 2016 | Aug 15, 2016 | $68.21B+5% | SEC ↗ |
| Q1 2016 | May 16, 2016 | $65.22B | SEC ↗ |